For more than 59 years, ELPEN Pharmaceuticals develops and manufactures for the Greek and international markets high quality, original and generic pharmaceutical products.
Experimental Research Center of ELPEN - An innovative idea with more than 25 years of contribution to Research and Education.
Our high quality standards, established know-how and leading market position, along with our strong salesforce and close relationships with the local scientific community, have made ELPEN the partner of choice for the Greek market
We emphasize on producing high quality and safe pharmaceutical products that contribute to the improvement of patients’ lives
ELPEN's Regulatory Affairs Department acts as an intermediary between the company and the competent national or international bodies and organizations.
ELPEN GmbH is a subsidiary that was founded in February of 2012 with the aim to become ELPEN's strategic point of development for Europe.
There are a number of reasons why ELPEN is now recognised as the partner of choice from leading domestic and international pharmaceutical companies.
of total revenues invested in R&D
The largest privately owned Research and Experimental Center in Greece
with modern facilities dedicated for the production of reliable pharmaceutical products
ELPEN’s subsidiary in Germany
ELPEN’s subsidiary in UAE
